Last reviewed · How we verify
NCT05000125
Comparison of the Hologic Genius Digital Diagnostics System With the ThinPrep Imaging System
trial testing Hologic's Genius Digital Diagnostics System in Cervical Cancer Screening in 1,994 participants. Completed in 31 December 2021.
27 September 2021
Quick facts
| Lead sponsor | Hologic Deutschland GmbH |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,994 |
| Start date | 20 August 2021 |
| Primary completion | 27 September 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Hologic's Genius Digital Diagnostics System
Conditions studied
- Cervical Cancer Screening — all drugs for Cervical Cancer Screening →
Sponsor
Hologic Deutschland GmbH
Who can join
Adults 35 to 90, female only, with Cervical Cancer Screening. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Quality assurance of the laboratory examinations. Retrospective non-interventional study with ThinPrep slides collected as part of the German Co-Screening Program for routine diagnostic. These slides will retrospectively be used to validate the Hologic Genius Digital Cytology (DC) system vs. the ThinPrep Imaging system (TIS).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05000125
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hologic's Genius Digital Diagnostics System
Trials testing the same drug.
- NCT04965857 — Comparison of the Hologic Genius Digital Diagnostics System With the Liquid-based Cytology (LBC) Manual Microscopy · unknown
Other recruiting trials for Cervical Cancer Screening
Currently open trials in the same condition.
- NCT06968871 — Ameliorated Pap Tests and Cervical Cancer Screening Participation · NA · recruiting
- NCT05286034 — Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme · NA · recruiting
- NCT07171658 — Breast Cancer-Related Approach for Increasing Cervical Cancer Screening · NA · recruiting
- NCT07581873 — Education and Health in Women With Cervical Cancer · NA · active not recruiting
- NCT07181278 — Optimization of Cervical Cancer Screening Strategies Among Women Living With HIV: Effectiveness and Implementation of De · NA · recruiting
Other Hologic Deutschland GmbH trials
Trials by the same sponsor.
- NCT04965857 — Comparison of the Hologic Genius Digital Diagnostics System With the Liquid-based Cytology (LBC) Manual Microscopy · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05000125 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hologic Deutschland GmbH
- Last refreshed: 15 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05000125.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing